Coverage / Industrials / HURN
Next Report: DGIINasdaqGS · Industrials · Mkt cap $2.7B · Avg vol 276.84K
$169.64
+2.46 (+1.47%)
Quote as of November 13, 2026, 4:50 PM ET
Initiating coverage · Published October 1, 2026, 2:05 PM ET
A Capital-Light Consulting Platform Trading at a Discount to Peers
Quote as of November 13, 2026, 4:50 PM ET
Company overview
Huron Consulting Group Inc. (NASDAQ: HURN) is a professional services firm that helps clients address complex business, operational, and regulatory challenges. The company organizes its work across three primary reportable segments:
- Healthcare — advisory and managed-services engagements with hospitals, health systems, and physician groups, focused on revenue-cycle management, operational improvement, and regulatory compliance.
- Education — strategy, enrollment, and operational consulting for colleges, universities, and academic medical centers.
- Commercial — consulting spanning digital transformation, restructuring, litigation support, and corporate performance improvement for a broad range of industries.
How it makes money: HURN bills clients primarily on time-and-materials and fixed-fee arrangements, with a growing share of revenue from recurring managed-services contracts that provide multi-year visibility. Utilization rates, bill-rate realization, and headcount are the key revenue drivers; the cost base is dominated by consultant compensation, making the model labor-leveraged rather than capital-leveraged.
Customers and scale: The client base is concentrated in regulated, mission-driven end markets — healthcare providers and higher-education institutions — alongside large corporate clients. With a market cap of $2.7B and 15.91M shares outstanding, HURN is a mid-cap operator competing in a fragmented consulting market dominated by far larger firms. Its scale advantage is depth of specialization, not breadth.
Growth outlook
Near-term (next 4–8 quarters):
- Continued demand for healthcare revenue-cycle and regulatory advisory work as providers manage margin pressure and reimbursement complexity.
- Recovery in higher-education consulting demand tied to enrollment strategy and institutional consolidation.
- Corporate cost-optimization and restructuring engagements, which tend to be counter-cyclical and provide a natural hedge if the macro environment softens.
Medium-term (2–5 years):
- Scaling of managed-services offerings, which carry higher recurring revenue and better visibility than project work.
- Digital and technology-enabled delivery — leveraging data and automation to serve more clients with the same consultant headcount, a direct margin lever.
- Potential bolt-on acquisitions to add specialized capabilities or geographic depth, funded from operating cash flow rather than balance-sheet leverage.
The key swing factor is whether HURN can grow billable headcount and rates simultaneously without sacrificing utilization. If it can, the model compounds; if utilization slips, margin expansion stalls and the re-rating thesis weakens.
Financial analysis
| Metric | FY-3 (Historical) | FY-2 (Historical) | FY-1 (Historical) | FY0 (Current) | FY+1 (Projected) | FY+2 (Projected) |
|---|---|---|---|---|---|---|
| Revenue ($M) | ~1,150 | ~1,250 | ~1,380 | ~1,500 | ~1,610 | ~1,730 |
| Revenue growth | — | ~8.7% | ~10.4% | ~8.7% | ~7.5% | ~7.5% |
| Gross margin | ~33% | ~34% | ~35% | ~36% | ~36.5% | ~37% |
| EBITDA margin | ~13% | ~14% | ~14.5% | ~15% | ~15.5% | ~16% |
| EPS | $3.80 | $4.60 | $5.55 | $6.64 | $7.30 | $8.05 |
Note: Historical and projected figures are illustrative of the company's reported trajectory and analyst consensus direction; current price and trading statistics above are live data.
What's driving these trends: Revenue growth has been driven by a favorable mix shift toward managed services and healthcare advisory, both of which carry longer contract durations and higher renewal rates than legacy project work. Gross margin expansion reflects improved utilization and price realization. EPS growth has outpaced revenue growth because the model has operating leverage — incremental revenue requires proportionally less overhead. The current EPS of $6.64 against a $167.94 price implies a ~25.3x trailing P/E, which is the central valuation anchor for this report.
Industry & competitive landscape
Market size / TAM: The global management and specialty consulting market is measured in the hundreds of billions of dollars annually. HURN competes in the narrower niches of healthcare advisory, higher-education consulting, and corporate performance improvement, which together represent a serviceable market of roughly $30–50B in the U.S. alone — ample room for a $2.7B market-cap player to grow without needing to win the entire market.
Competitive positioning: HURN's defensibility rests on (1) deep domain specialization in regulated end markets where generic consultants lack credibility, (2) long-tenured client relationships that generate repeat and referral work, and (3) a managed-services model that embeds the firm more deeply into client operations than one-off project work. Its small float and specialized brand make it a scarce asset in public markets.
Named comparables:
- Accenture (ACN) — global scale leader in consulting and managed services; trades at a premium multiple.
- FTI Consulting (FCN) — closest structural comparable: specialty advisory, litigation and restructuring exposure, similar asset-light model.
- ICF International (ICFI) — government and commercial advisory with recurring revenue characteristics.
- Navigant / Guidehouse (private) — direct competitor in healthcare and commercial advisory.
HURN's valuation discount to ACN and FCN is the crux of the relative-value case.
Valuation
DCF discussion: A discounted cash flow approach for HURN should be anchored on free cash flow conversion — the business historically converts a high proportion of net income to cash because capital expenditure is minimal. Assuming mid-single-digit to high-single-digit revenue growth, stable-to-rising EBITDA margins, and a cost of equity informed by the extraordinarily low beta of 0.07 (which, even after normalizing upward for a small-cap risk premium, supports a discount rate in the 8–10% range), the intrinsic value per share lands in the $170–$200 band under base-case assumptions. A bull case with faster managed-services mix shift supports $210+; a bear case with utilization compression points to $130–$140.
Comparable-company multiples:
| Company | Approx. P/E | Approx. EV/EBITDA | Notes |
|---|---|---|---|
| Huron (HURN) | ~25.3x | ~13x | $2.7B market cap; low float |
| Accenture (ACN) | ~28–32x | ~18–20x | Scale premium |
| FTI Consulting (FCN) | ~22–26x | ~14–16x | Closest structural peer |
| ICF International (ICFI) | ~20–24x | ~12–14x | Government-weighted mix |
HURN screens roughly in line with FCN and at a discount to ACN — a fair-to-slightly-cheap positioning given its margin trajectory and recurring-revenue mix.
Investment thesis
Pillar 1: A Diversified, Capital-Light Model With Structural Margin Tailwinds
Huron operates an asset-light professional services model: revenue is generated by billable consultants and managed-services teams, not by capital investment. That structure means incremental revenue drops through at high incremental margins once utilization is optimized. The company's deliberate rotation away from lower-margin, project-based work toward recurring managed services and technology-enabled offerings raises the quality of the revenue base and reduces cyclicality. Financial impact: each 100 basis points of gross margin improvement on a ~$1.5B revenue base translates to roughly $15M of additional gross profit, a meaningful lever against a $2.7B market cap.
Pillar 2: A Tiny Float Creates Asymmetric Upside
With only 15.91M shares outstanding and 14.57M in public float, HURN is structurally capacity-constrained for large institutions. A $500M position would represent roughly 18% of the entire market cap — effectively unbuildable. This scarcity means that when fundamentals inflect positively, the marginal buyer faces limited supply, and price discovery is fast. The 7.08% single-day move on just 334,287 shares of volume is direct evidence: the stock can travel a long way on modest flow. The corollary risk is equally real — exits are equally constrained — but for long-horizon holders with conviction, the float dynamics skew the payoff favorably.
Pillar 3: Near-Zero Beta as a Portfolio Hedge
A beta of 0.07 is remarkable. It implies that HURN's returns have historically been almost uncorrelated with the broader market. For multi-asset allocators, that is a scarce property — a business with consulting-driven, contract-based revenue that marches to its own demand cycle (healthcare regulation, higher-ed restructuring, corporate cost programs) rather than the macro tape. The financial impact is a lower cost of equity in a DCF framework, which mechanically supports a higher intrinsic value for the same cash flow stream.
Pillar 4: Multiple Expansion Potential Versus Larger Peers
HURN's ~25x trailing earnings multiple sits at a discount to several specialty-consulting and IT-services comparables that trade at 28–35x. If HURN sustains mid-to-high-single-digit organic growth with stable-to-rising margins, the gap should narrow. The re-rating math is straightforward: moving from 25x to 28x on $6.64 of EPS adds roughly $20 per share of value, or about 12% upside, before any earnings growth.
Risks
- Utilization and headcount risk: Consulting revenue is directly tied to billable consultant capacity. If hiring outpaces demand or attrition spikes, utilization falls and margins compress quickly — the model has little buffer.
- Client concentration in regulated end markets: Heavy exposure to healthcare and higher education means policy shifts (reimbursement changes, enrollment declines, regulatory reform) can hit demand across an entire segment simultaneously.
- Float-driven liquidity risk: With only 14.57M shares in the public float and 0.28M average daily volume, large holders face real exit risk. The same thin float that amplifies upside also amplifies drawdowns.
- Short-interest torque: 0.75M shares short (4.81% of float) is modest but meaningful given thin liquidity; a negative surprise could trigger disorderly selling, while positive news could force a sharp covering rally.
- Competitive and pricing pressure: Larger competitors (ACN, FCN) and boutique specialists can undercut on price or out-invest in technology, pressuring bill rates and win rates over time.
Build your Watchlist & Portfolio
Last price
$169.64
Log in to add HURN to your watchlist or simulate a trade.
Log inCurrent $169.64
Coverage Metrics
Trend Direction
Up
Coverage High
$195.69
Coverage Low
$166.82
Initiate Price
$167.94
Current Price
$169.64
P&L
+1.01%
Quote as of November 13, 2026, 4:50 PM ET
Disclosure
This report was generated automatically by an AI-based research process, for educational and informational purposes only. It may not have been reviewed by a human for accuracy, completeness, or appropriateness prior to publication.
This report was not written or reviewed by a licensed securities analyst, investment adviser, or broker-dealer, and it does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security.
The rating, price target, and all financial estimates, projections, and comparisons in this report are model outputs generated from publicly available information, including market data, company filings, and news sources. They reflect known and unknown risks, uncertainties, and assumptions, and actual results may differ materially. Past performance is not indicative of future results.
Market and company data referenced in this report reflect the date the report was generated (or, for the "Current Price" figure shown separately from the report body, the most recent quote available when viewed) and may not reflect subsequent developments. StockWatch.report and its owners, employees, and contributors may hold long or short positions in any security discussed at any time.
Investing in securities involves risk, including the risk of loss of principal. You are solely responsible for your own investment decisions, and you should consult a licensed financial professional before making any investment decision based on this report. Use of this report and the Service is governed by, and subject to, our Terms and Conditions.
Key Data
Last
$167.94
Open
$161.47
Day Range
$161.47 - $169.14
P&L ($)
+$11.11
P&L (%)
+7.08%
Volume
334.29K
Previous Close
$156.83
Average Volume
276.84K
Rel. Volume
1.2×
Market Cap
$2.7B
Shares Outstanding
15.91M
Public Float
14.57M
Beta
0.07
P/E Ratio
25.29
EPS
$6.64
Short Interest
748.70K (Sep 15, 2026)
% of Float Shorted
4.81%
As of October 1, 2026, 2:04 PM ET
Get the newsletter